Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Clinical trial NCT04045691 · RECRUITING
Trial details
- NCT number
- NCT04045691
- Sponsor
- Pierre Fabre Pharma GmbH
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-17
- Primary completion
- 2026-12-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.